Pay in 4 interest-free payments of $5.78 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
AOD9604 and Energy Balance Research In obese ob/ob and lean C57BL/6J mice treated for 14 days via mini-osmotic pumps, AOD9604 significantly reduced body weight gain in obese mice, associated with increased in vivo fat oxidation and increased plasma glycerol levels as an index of enhanced lipolysis without the hyperglycaemia or reduced insulin secretion associated with intact hGH treatment
This has a huge impact on both personal wellbeing and the economy
It does contain a cyanide molecule, which is important to be made aware of
AOD-9604 is sold by Omnix Peptides strictly for laboratory, research, or analytical purposes
This is not a complete list of side effects or contraindications
US$ 20.42
US$ 24.90
US$ 20.73
US$ 23.07
US$ 23.10
